comparemela.com

Latest Breaking News On - Primary membranous - Page 1 : comparemela.com

FDA Grants Orphan Drug Designation to Felzartamab for Kidney Transplant Recipients

Previously, felzartamab received orphan drug designation and breakthrough therapy designation for the treatment of primary membranous nephropathy.

United statesUptal patelDrug administration for primary membranous nephropathyAmerican society of nephrology kidney weekOrphan drug designationHuman immunology biosciencesAmerican societyNephrology kidney weekBreakthrough therapy designationBio receivesDrug designationAntibody mediated rejectionKidney transplantBio announces positive phasePrimary membranousDrug administration

Investigational mAb Felzartamab Provides Promising Data for PMN

Positive phase 2 data from 2 studies on the investigational monoclonal antibody felzartamab designed to deplete CD38+ plasma cells, demonstrated reduced pathogenic antibody levels in primary membranous nephropathy.

Brad rovinTravis murdochDivision of nephrology at ohio state universityDrug administrationHuman immunology biosciencesOhio state universityBio announces positive phasePrimary membranous

$63.4 million for rare cancers and rare diseases research

Research into some of the world’s rarest forms of cancer and disease have received a boost, with the Morrison Government announcing 27 grant

University of adelaideSouth australiaFlinders universityNew south walesGovernment long term national health planMonash universityCoalition governmentEdith cowan universityUniversity of queenslandQueensland university of technologyMurdoch childrens research instituteA multicomponent exercise medicine programme in patientsUniversity of sydneyUniversity of new south walesUniversity of melbourneResearch future fund

vimarsana © 2020. All Rights Reserved.